CIK: 1743780 - Address: C/O Igm Biosciences, Inc., 325 E. Middlefield Road, Mountain View, CA 94043
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/15/24 19:55
3/13/24
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS.m-5410.010-5-594D
12/1/23 19:03
11/29/23
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS-76.210-1-254D
5/25/23 19:24
5/23/23
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS-1512.310-1-255D
3/16/23 18:31
3/14/23
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS-3318.730-2-629D
12/20/22 20:12
12/16/22
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS-10318.980-5-1531D
11/28/22 20:31
11/23/22
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS-1921.570-1-236D
5/26/22 16:49
5/24/22
IGMSIgm Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS-1617.100-1-237D
4/3/20 17:53
4/1/20
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS.d-7,55795.420-79-954D
4/3/20 17:53
4/1/20
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeM.d3784.770794D
12/11/19 21:57
12/10/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS.d-35035.000-10-1000D
12/11/19 21:57
12/10/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeM.d202.020100D
12/10/19 21:53
12/9/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeM.d202.020100D
12/10/19 21:53
12/9/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS.d-30030.000-10-1000D
8/21/19 11:37
8/16/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS-46.360-1-1000D
5/7/19 19:33
5/3/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS.d-14417.990-8-1000D
5/7/19 19:33
5/3/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeM.d162.02080D
4/8/19 19:20
4/4/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS.d-13116.390-8-1000D
4/8/19 19:20
4/4/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeM.d162.02080D
3/6/19 20:55
3/4/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS.d-13616.940-8-1000D
3/6/19 20:55
3/4/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeM.d162.02080D
2/21/19 19:45
2/19/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS-3815.050-3-1000D
2/5/19 19:02
2/4/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS.d-11914.860-8-1000D
2/5/19 19:02
2/4/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeM.d162.02080D
1/8/19 20:17
1/4/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeM.d162.02080D
1/8/19 20:17
1/4/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsTakimoto Chris HCAOChief MeS.d-12415.550-8-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact